Medico Remedies Limited
Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations
What Medico files
- Others37
- Board Meeting10
- Important8
- New Orders6
- Updates3
- Results2
Medico Remedies is expanding capacity with a new plant to produce 25M tablets, 45M capsules, 10M dry syrups, and 10M injectables annually, focusing on antibiotic formulations for export markets. The Rs 30 Cr investment, funded via internal accruals and debt, will be executed over two years and is expected to...
Medico Remedies Limited has submitted its integrated financials for the quarter and nine months ending December 31, 2024, following compliance with SEBI regulations. The company’s financial results, reviewed and approved by the board, indicate that sales within India totaled ₹21,472.44 cr, while international sales were ₹38,842.90 cr. The total revenue...
**Consolidated Financials:** For the quarter ended 31st December 2024, Medico Remedies Limited reported total revenues of ₹39.14 crore (cr), reflecting a solid demand in both domestic and international markets. **Revenue Growth:** The revenue grew significantly compared to the previous quarter, with an increase attributed to enhanced sales strategies and market...
Mr. Rishit Mehta, a member of the Promoter Group of Medico Remedies Limited, has submitted a disclosure regarding the sale of 18,00,000 equity shares. This transaction could have implications for shareholder sentiment, as sales by promoters can be viewed as a signal regarding the company’s outlook. Close attention may be...
Ms. Shweta Mehta, a member of the Promoter Group of Medico Remedies Limited, has disclosed the sale of 9,00,000 equity shares. This transaction is part of the company's compliance with SEBI regulations concerning insider trading. The sale's implications for stock performance and potential shifts in shareholder composition warrant close observation....